Literature DB >> 24063998

Interleukin-1 beta in unstimulated whole saliva is a potential biomarker for oral squamous cell carcinoma.

T Kamatani1, S Shiogama, Y Yoshihama, S Kondo, T Shirota, S Shintani.   

Abstract

The objective of this study was to evaluate cytokines in unstimulated whole saliva (UWS) of oral squamous cell carcinoma (OSCC) patients as compared to those with pre- and post-operation for evaluation as markers of OSCC. Sixteen OSCC patients were included in this study. Cytokine concentrations in resting saliva were measured using a Bio-Plex suspension array system. Only interleukin-1 (IL-1) beta showed significantly different cytokine concentration in saliva between pre- and post-operation. IL-1 beta was released from cultured OSCC cells confirmed by ELISA and immunohistochemistry. From this study, IL-1 beta in UWS may be useful for detection of early stage OSCC. More studies are needed to accept the utility of IL-1 beta in UWS for predicting, diagnosis and evaluation of OSCC.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Interleukin-1 beta; Oral squamous cell carcinoma; Unstimulated whole saliva

Mesh:

Substances:

Year:  2013        PMID: 24063998     DOI: 10.1016/j.cyto.2013.08.011

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  11 in total

1.  Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients.

Authors:  Swati Tomar; Christian A Graves; Diego Altomare; Sangeeta Kowli; Susannah Kassler; Natalie Sutkowski; M Boyd Gillespie; Kim E Creek; Lucia Pirisi
Journal:  Head Neck       Date:  2015-06-15       Impact factor: 3.147

Review 2.  The inflammasome and danger molecule signaling: at the crossroads of inflammation and pathogen persistence in the oral cavity.

Authors:  Özlem Yilmaz; Kyu Lim Lee
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

3.  Expression of prostaglandin E2 prostanoid receptor EP2 and interleukin-1β in laryngeal carcinoma - preliminary study.

Authors:  Marcin Mochocki; Piotr Morawski; Renata Kopta; Ewa Brzezińska-Błaszczyk; Olga Stasikowska; Iwona Lewy-Trenda; Katarzyna Starska
Journal:  Contemp Oncol (Pozn)       Date:  2015-05-13

4.  Stromal-epithelial lactate shuttle induced by tumor‑derived interleukin‑1β promotes cell proliferation in oral squamous cell carcinoma.

Authors:  Jie Wu; Yun Hong; Tong Wu; Juan Wang; Xiaobing Chen; Zhi Wang; Bin Cheng; Juan Xia
Journal:  Int J Mol Med       Date:  2017-11-17       Impact factor: 4.101

5.  Salivary cytokine panel indicative of non-small cell lung cancer.

Authors:  Tomonobu Koizumi; Vivek Shetty; Masaki Yamaguchi
Journal:  J Int Med Res       Date:  2018-06-19       Impact factor: 1.671

Review 6.  Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review.

Authors:  Elena Ferrari; Margherita E Pezzi; Diana Cassi; Thelma A Pertinhez; Alberto Spisni; Marco Meleti
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

Review 7.  Interleukin 1β-A Potential Salivary Biomarker for Cancer Progression?

Authors:  Adi Idris; Nur B Ghazali; David Koh
Journal:  Biomark Cancer       Date:  2015-07-08

8.  Expression of Interleukin-1ß and Interleukin-8 in Oral Potentially Malignant Disorders and Carcinomas.

Authors:  Jeaneth Lopez-Labady; Ronell Bologna-Molina; Mariana Villarroel-Dorrego
Journal:  Front Oral Health       Date:  2021-09-10

Review 9.  IL-1/IL-1R Signaling in Head and Neck Cancer.

Authors:  Sven E Niklander; Craig Murdoch; Keith D Hunter
Journal:  Front Oral Health       Date:  2021-08-26

Review 10.  Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential.

Authors:  Sven E Niklander
Journal:  Front Oral Health       Date:  2021-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.